Press Releases


April 2, 2014 - Collegium Pharmaceutical Announces Positive Topline Results of Clinical Study Evaluating the Effect of Crushing Oxycodone DETERx® Compared with OxyContin®
March 19, 2014 - Collegium Pharmaceutical Announces Allowance of New Claims Covering DETERx®, an Abuse-Deterrent, Extended-Release, Technology Platform
February 4, 2014 - Collegium Pharmaceutical Announces Completion of Enrollment in Pivotal Phase 3 Clinical Study for Oxycodone DETERx®, its Lead Abuse-Deterrent Development Program
January 15, 2014 - Collegium Pharmaceutical Announces Positive Topline Results of Human Abuse Potential Study Evaluating Intranasal Administration of Crushed Oxycodone DETERx®, an Abuse-Deterrent, Extended-Release Product
October 29, 2013 -“Challenges of Treating Patients with Chronic Pain with Dysphagia (CPD): Physician and Patient Perspectives,” Published in Peer-Reviewed Medical Journal
October 17, 2013 - Collegium Pharmaceutical Announces Issuance of U.S. Patent and Allowance of New Claims Covering Oxycodone DETERx®, an Abuse-Deterrent, Extended-Release Opioid Product
September 3, 2013 - Collegium Pharmaceutical’s Oxycodone DETERx®, an Abuse-Deterrent, Extended-Release Opioid, to be featured at PAINWeek 2013
July 24, 2013 - Collegium Pharmaceutical Announces Successful Completion of Clinical Study Evaluating Intranasal Administration of Oxycodone DETERx®, an Abuse-Deterrent, Extended-Release Opioid Product
July 18, 2013 - Collegium Pharmaceutical, Inc. Announces Notice of Allowance for U.S. Patent Covering Oxycodone DETERx®, an Abuse-Deterrent, Extended-Release Opioid Product
June 20, 2013 - Collegium Pharmaceutical, Inc. Announces Issuance of an Additional U.S. Patent Covering Oxycodone DETERx®, an Abuse-Deterrent, Extended-Release Opioid Product
May 31, 2013 - Collegium Pharmaceutical’s CEO to Present at the Jefferies 2013 Global Health Care Conference in New York on June 4, 2013
May 17, 2013 - Collegium Pharmaceutical’s CEO to Present at the UBS Global Health Care Conference in New York on May 20, 2013
May 8, 2013 - Collegium Announces Poster Presentation for Oxycodone DETERx®, an Abuse-Deterrent, Extended-Release Opioid at American Pain Society’s 32nd Annual Scientific Meeting
April 30, 2013 - Collegium Announces Results of Chronic Pain Patient Survey – Confirms Significant Unmet Medical Need for a Differentiated, Abuse-Deterrent, Extended-Release Opioid
April 22, 2013 - Significant Unmet Medical Need for Treatment of Patients with Chronic Pain with Dysphagia (CPD)
April 17, 2013 - Collegium Pharmaceutical Announces Successful Completion of Clinical Study Evaluating the Impact of Tampering on Oxycodone DETERx®, an Abuse-Deterrent, Extended-Release Opioid Product
April 3, 2013 - Collegium Pharmaceutical Names Douglas Carlson to Vice President of Business Development
February 28, 2013 - Collegium Pharmaceutical’s CEO to Present at the Cowen & Company 33rd Annual Health Care Conference in Boston on March 6, 2013
February 12, 2013 - Collegium Pharmaceutical Inc. Announces Notice of Allowance for U.S. Patent Covering Oxycodone DETERx®, a Tamper-Resistant, Extended-Release Opioid Product
January 17, 2013 - Collegium Pharmaceutical Announces Relocation to Massachusetts